Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells

Topoisomerases as anticancer targets

(2018) Justine L. Delgado et al.   BIOCHEMICAL JOURNAL

Tetrandrine and cancer – An overview on the molecular approach

(2018) Bhagya N. et al.   BIOMEDICINE & PHARMACOTHERAPY

MDR1 in immunity: friend or foe?

(2018) Marion Bossennec et al.   OncoImmunology

Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling

(2017) Yandong Lu et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer

(2017) Mengjuan Jiang et al.   MOLECULAR PHARMACEUTICS

Boschniakia Rossica Polysaccharide Triggers Laryngeal Carcinoma Cell Apoptosis by Regulating Expression of Bcl-2, Caspase-3, and P53

(2017) Chunping Yao et al.   MEDICAL SCIENCE MONITOR

Tetrandrine – A molecule of wide bioactivity

(2016) N. Bhagya et al.   PHYTOCHEMISTRY

Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells

(2016) Dawei Li et al.   Oncology Letters

Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy

(2016) Ting Liu et al.   Oncotarget

Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance

(2015) Subburayan Karthikeyan et al.   Anti-Cancer Agents in Medicinal Chemistry

HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP

(2015) Wanyuan Bao et al.   BIOMEDICINE & PHARMACOTHERAPY

p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines

(2015) Shunan Ye et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6

(2015) Hua Sun et al.   JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance

(2014) Nagaraju Anreddy et al.   MOLECULES

Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells

(2014) Yan Fang Sun et al.   PHYTOMEDICINE

Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer Hep-2 cells

(2013) Wanzhong Yin et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

The Combinational Effect of Vincristine and Berberine on Growth Inhibition and Apoptosis Induction in Hepatoma Cells

(2013) Ling Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Effect of D, L‐threo‐1‐phenyl‐2‐decanoylamino‐3‐morpholino‐1‐propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells

(2011) Baoan Chen et al.   Hematology

A Novel Calmodulin Antagonist O-(4-Ethoxyl-Butyl)-Berbamine Overcomes Multidrug Resistance in Drug-Resistant MCF-7/ADR Breast Carcinoma Cells

(2010) Rong Liu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Multiple Drug Resistance Mechanisms in Cancer

(2010) Bruce C. Baguley   MOLECULAR BIOTECHNOLOGY

Emerging role of nuclear protein 1 (NUPR1) in cancer biology

(2009) Uttio Roy Chowdhury et al.   CANCER AND METASTASIS REVIEWS

Definitive chemotherapy: a new frontier in the fight against laryngeal cancer

(2009) Missak Haigentz et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

NUPR1 Interacts with p53, Transcriptionally Regulates p21 and Rescues Breast Epithelial Cells from Doxorubicin-Induced Genotoxic Stress

(2008) David Clark et al.   CURRENT CANCER DRUG TARGETS